Recruiting

Continuous Glucose Monitors

Sponsor:

University of Colorado, Denver

Code:

NCT06575842

Conditions

Type 1 Diabetes

Eligibility Criteria

Sex: All

Age: 2 - 26

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.

Conditions

Type 1 Diabetes

Study ID

NCT06575842

Start date

Aug 21, 2024

Status verified date

Jun, 2026

Completion date

Dec 1, 2027

Anticipated

Primary completion date

Dec 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 2 - 26

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Participants will be 2 to 26 years of age at the time of enrollment.
2. Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period.
3. Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account.

Exclusion Criteria:

1. Pregnancy.
2. Currently using hydroxyurea.
3. A condition that the investigator determines would prevent the patient from participation.

Study Design

Enrollment

120 participants

Anticipated

Interventions and Outcome Measures

Arms

Pediatric patients undergoing anesthesia

Pediatric patients who are undergoing a surgical procedure with anesthesia. Patients will have type 1 diabetes and be wearing a continuous glucose monitor as part of routine care.

Primary outcome measure

  • Accuracy of CGM compared to blood glucose using standard statistical methods including mean absolute relative difference (MARD). [ Time Frame: Perioperatively (length of time will vary based on the operative procedure) ]

Central Contacts and Locations

Central contacts

Erin Cobry, MD

3037242323Erin.Cobry@cuanschutz.edu

Locations

Barbara Davis Center

Recruiting

Aurora, Colorado, United States, 80045

Contacts

Erin Cobry, MD

303-724-2323erin.cobry@cuanschutz.edu

Principal Investigator:

Erin Cobry, MD

More Information

Sponsor

University of Colorado, Denver

Last update posted

Jun 12, 2026

Last verified

Jun, 2026

Keywords

  • Anesthesia
  • Continuous glucose monitors
  • Accuracy
  • Pediatrics

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2026-06-12.